— Know what they know.
Not Investment Advice

SPRY NASDAQ

ARS Pharmaceuticals, Inc.
1W: -0.2% 1M: -30.1% 3M: -51.1% YTD: -64.6% 1Y: -59.7% 3Y: +11.8% 5Y: -61.6%
$4.07
-0.05 (-1.21%)
 
Weekly Expected Move ±8.1%
$3 $4 $4 $4 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 23 · $404.2M mcap · 64M float · 2.88% daily turnover · Short 71% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
47.0 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: -424.3%
Cost Advantage
46
Intangibles
44
Switching Cost
65
Network Effect
48
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. SPRY shows a Weak competitive edge (47.0/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Switching Costs. Negative ROIC of -424.3% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$15
Low
$15
Avg Target
$15
High
Based on 1 analyst since Aug 13, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 3Hold: 6Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$15.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-08 Leerink Partners — $26 $15 -11 +166.9% $5.62
2026-04-09 Northland Securities — Initiated $25 — +202.3% $8.27
2026-03-10 Leerink Partners Roanna Ruiz $18 $26 +8 +180.2% $9.28
2025-11-04 Roth Capital Kyle Bauser Initiated $30 — +256.5% $8.41
2025-09-26 Raymond James — $22 $32 +10 +230.4% $9.69
2024-08-19 Cantor Fitzgerald Josh Schimmer Initiated $30 — +110.7% $14.24
2024-08-12 Raymond James Strong Buy $18 $22 +4 +102.8% $10.85
2024-07-25 Raymond James Ryan Deschner Initiated $18 — +73.1% $10.40
2024-03-05 Leerink Partners Roanna Ruiz $14 $18 +4 +108.1% $8.65
2022-12-13 Leerink Partners — Initiated $14 — +96.6% $7.12

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
Oct 02, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. SPRY receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-03-09 C- D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 14 Grade D
Profitability
19
Balance Sheet
0
Earnings Quality
44
Growth
36
Value
32
Momentum
37
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. SPRY scores highest in Earnings Quality (44/100) and lowest in Balance Sheet (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-1.92
Distress Zone
Piotroski F-Score
2/9
✗ ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✓
Beneish M-Score
-1.72
Possible Manipulator
Ohlson O-Score
-0.12
Bankruptcy prob: 46.9%
Moderate
Credit Rating
B-
Score: 22.5/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.91x
Accruals: -6.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. SPRY scores -1.92, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. SPRY scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. SPRY's score of -1.72 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. SPRY's implied 46.9% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. SPRY receives an estimated rating of B- (score: 22.5/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-1.87x
PEG
0.02x
P/S
3.46x
P/B
32.31x
P/FCF
-4.05x
P/OCF
—
EV/EBITDA
-3.98x
EV/Revenue
7.04x
EV/EBIT
-3.91x
EV/FCF
-4.19x
Earnings Yield
-27.08%
FCF Yield
-24.71%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. SPRY currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.023
EBT / EBIT
×
EBIT Margin
-1.801
EBIT / Rev
×
Asset Turnover
0.415
Rev / Assets
×
Equity Multiplier
2.748
Assets / Equity
=
ROE
-210.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. SPRY's ROE of -210.3% is driven by Asset Turnover (0.415), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1463 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$4.07
Median 1Y
$2.14
5th Pctile
$0.58
95th Pctile
$7.94
Ann. Volatility
81.9%
Analyst Target
$15.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Richard Lowenthal, M.S.,
MSEL President and Chief Executive Officer
$700,000 $— $9,656,400
Sarina Tanimoto, M.D.,
M.B.A. Chief Medical Officer
$540,000 $— $5,290,471
Justin Chakma Business
siness Officer
$497,000 $— $2,888,109

CEO Pay Ratio

7:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $9,656,400
Avg Employee Cost (SGA/emp): $1,456,468
Employees: 158

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
158
+1.9% YoY
Revenue / Employee
$533,405
Rev: $84,278,000
Profit / Employee
$-1,084,165
NI: $-171,298,000
SGA / Employee
$1,456,468
Avg labor cost proxy
R&D / Employee
$83,424
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -4.5% 64.7% -6.9% -16.1% -14.2% -28.7% -15.3% -52.2% -46.8% -21.6% -20.5% -19.3% -22.4% 3.3% -6.9% -23.6% -45.9% -92.3% -1.4% -2.1% -2.10%
ROA -4.3% -32.9% -6.6% -11.9% -12.9% -20.2% -14.5% -35.0% -42.8% -21.1% -19.9% -18.7% -21.1% 2.7% -5.6% -17.9% -27.1% -50.5% -64.4% -76.5% -76.53%
ROIC -30.4% 18.7% -38.9% 23.3% 3.9% 27.7% 12.6% 14.8% 13.4% -19.9% -108.1% 13.4% 13.5% 5.2% 45.8% 1.0% 51.6% 4.2% 3.7% -4.2% -4.24%
ROCE -4.3% -36.5% -7.4% -62.2% -79.7% -12.9% -18.0% -24.7% -30.6% -29.3% -27.7% -26.4% -30.1% -0.9% -9.0% -21.1% -26.7% -60.5% -82.2% -1.1% -1.12%
Gross Margin -8.7% -4.2% -7.2% -8.4% -19.1% — -321.6% -719.8% — — — 1.0% 94.6% 95.5% 49.3% 68.3% 74.8% 88.6% 72.3% 61.8% 61.83%
Operating Margin -10.6% -6.6% -10.7% -13.7% -35.1% — -935.6% -2060.3% — — — -30.7% -10.5% 54.5% -4.7% -3.0% -1.6% -1.5% -2.7% -1.8% -1.83%
Net Margin -11.0% -6.8% -10.9% -13.8% -34.8% — -748.0% -1737.0% — — — -25.0% -9.2% 57.7% -4.3% -2.9% -1.6% -1.5% -2.7% -1.9% -1.85%
EBITDA Margin -10.6% -6.3% -10.6% -13.7% -35.0% — -934.6% -2058.3% — — — -30.6% -10.5% 54.5% -4.6% -2.8% -1.5% -1.5% -2.5% -1.8% -1.77%
FCF Margin -9.7% -12.4% -15.5% -22.8% -20.1% -30.6% -68.3% -254.1% -2091.7% -1981.4% -5361.2% -88.5% -17.9% 14.6% -21.7% -47.5% -60.2% -2.0% -1.8% -1.7% -1.68%
OCF Margin -9.6% -12.1% -15.2% -22.6% -19.8% -30.5% -67.7% -252.4% -2078.6% -1975.5% -5354.7% -88.3% -17.9% 15.2% -21.1% -47.0% -59.8% -2.0% -1.8% -1.7% -1.68%
ROE 3Y Avg snapshot only -5.89%
ROA 3Y Avg snapshot only -40.62%
ROIC 3Y Avg snapshot only -1.83%
ROIC Economic snapshot only -93.99%
Cash ROA snapshot only -78.72%
Cash ROIC snapshot only -4.88%
CROIC snapshot only -4.88%
NOPAT Margin snapshot only -1.46%
Pretax Margin snapshot only -1.84%
R&D / Revenue snapshot only 13.02%
SGA / Revenue snapshot only 2.43%
SBC / Revenue snapshot only 26.72%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -23.13 -11.53 -14.41 -16.15 -19.50 -23.12 -14.47 -11.92 -5.86 -9.69 -19.84 -18.38 -28.65 129.21 -78.82 -35.75 -12.41 -6.70 -4.03 -3.69 -1.867
P/S Ratio 73.51 42.39 81.13 165.04 239.18 609.28 911.47 2903.68 12042.66 17559.98 98609.18 1648.01 547.89 11.59 12.70 15.28 6.96 13.63 8.06 6.80 3.457
P/B Ratio 1.05 -7.46 1.12 -9.03 19.13 2.94 2.35 2.56 1.52 2.28 4.40 3.83 7.00 4.02 5.39 8.92 6.73 10.05 13.01 63.58 32.305
P/FCF -7.55 -3.43 -5.24 -7.23 -11.93 -19.91 -13.35 -11.43 -5.76 -8.86 -18.39 -18.63 -30.57 79.59 -58.59 -32.15 -11.54 -6.71 -4.55 -4.05 -4.046
P/OCF — — — — — — — — — — — — — 76.28 — — — — — — —
EV/EBITDA -3.78 -9.48 -3.70 -15.17 -18.74 -15.02 -7.46 -6.29 -1.65 -4.43 -12.31 -10.68 -19.89 -239.49 -35.85 -26.39 -8.50 -5.84 -3.61 -3.98 -3.977
EV/Revenue 11.54 33.12 19.93 149.54 224.21 401.15 519.02 1753.77 3990.16 9957.11 76267.68 1210.84 468.24 8.07 9.86 13.16 4.95 11.87 7.00 7.04 7.041
EV/EBIT -3.78 -9.37 -3.66 -15.00 -18.54 -14.86 -7.41 -6.26 -1.65 -4.42 -12.30 -10.67 -19.87 -233.36 -35.39 -26.11 -8.21 -5.73 -3.54 -3.91 -3.909
EV/FCF -1.18 -2.68 -1.29 -6.55 -11.18 -13.11 -7.60 -6.90 -1.91 -5.03 -14.23 -13.69 -26.12 55.41 -45.50 -27.69 -8.21 -5.84 -3.95 -4.19 -4.187
Earnings Yield -4.3% -8.7% -6.9% -6.2% -5.1% -4.3% -6.9% -8.4% -17.1% -10.3% -5.0% -5.4% -3.5% 0.8% -1.3% -2.8% -8.1% -14.9% -24.8% -27.1% -27.08%
FCF Yield -13.2% -29.2% -19.1% -13.8% -8.4% -5.0% -7.5% -8.8% -17.4% -11.3% -5.4% -5.4% -3.3% 1.3% -1.7% -3.1% -8.7% -14.9% -22.0% -24.7% -24.71%
PEG Ratio snapshot only 0.018
EV/Gross Profit snapshot only 9.528
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 19.90 7.42 17.65 6.08 4.69 51.01 27.18 25.37 21.87 96.85 60.90 32.82 12.56 14.26 11.00 6.17 6.66 7.28 4.94 3.48 3.475
Quick Ratio 19.90 7.42 17.65 6.08 4.69 51.01 27.18 25.37 21.87 96.85 60.90 32.82 12.52 14.04 10.74 5.98 6.51 7.06 4.77 3.28 3.283
Debt/Equity 0.02 -0.29 0.02 -0.16 0.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.85 1.57 13.72 13.715
Net Debt/Equity -0.89 — -0.85 — -1.20 -1.00 -1.01 -1.01 -1.02 -0.99 -1.00 -1.02 -1.02 -1.22 -1.20 -1.24 -1.94 -1.30 -1.70 2.22 2.219
Debt/Assets 0.02 0.15 0.02 0.16 0.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.30 0.34 0.69 0.688
Debt/EBITDA -0.43 -0.47 -0.25 -0.31 -0.26 -0.01 -0.01 -0.01 -0.00 -0.00 -0.00 -0.00 -0.00 -0.01 -0.00 -0.03 -0.02 -0.57 -0.50 -0.83 -0.829
Net Debt/EBITDA 20.33 2.65 11.36 1.57 1.25 7.79 5.64 4.13 3.34 3.38 3.61 3.86 3.38 104.52 10.32 4.26 3.45 0.86 0.54 -0.13 -0.134
Interest Coverage — — — — — -162.92 -216.19 -281.60 -333.66 — — — — — — — — — -80.14 -42.80 -42.803
Equity Multiplier 1.06 -1.97 1.07 -1.05 1.54 1.03 1.04 1.04 1.05 1.01 1.02 1.03 1.08 1.37 1.43 1.63 2.52 2.87 4.69 19.94 19.940
Cash Ratio snapshot only 2.363
Debt Service Coverage snapshot only -42.075
Cash to Debt snapshot only 0.838
FCF to Debt snapshot only -1.146
Defensive Interval snapshot only 230.0 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.01 0.09 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.31 0.35 0.42 0.48 0.25 0.32 0.42 0.415
Inventory Turnover — — — — — — — — — — — — 24.48 3.54 2.21 2.98 4.97 3.01 2.82 2.99 2.989
Receivables Turnover — 5506.00 — 137.66 — 2632.00 2.58 12.51 0.07 0.08 0.02 1.85 3.24 19.88 19.58 8.75 7.67 5.03 5.21 3.25 3.250
Payables Turnover 9.51 11.35 5.73 10.05 8.36 7.88 5.60 10.15 6.14 16.60 11.03 4.88 1.56 1.74 3.26 1.38 2.53 2.62 5.15 0.81 0.811
DSO 0 0 0 3 0 0 142 29 4952 4836 20805 198 113 18 19 42 48 73 70 112 112.3 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 15 103 165 122 73 121 130 122 122.1 days
DPO 38 32 64 36 44 46 65 36 59 22 33 75 234 210 112 264 144 139 71 450 450.1 days
Cash Conversion Cycle -38 -32 -64 -34 -44 -46 76 -7 4892 4814 20772 123 -107 -89 72 -100 -23 55 129 -216 -215.7 days
Fixed Asset Turnover snapshot only 56.080
Operating Cycle snapshot only 234.5 days
Cash Velocity snapshot only 0.813
Capital Intensity snapshot only 2.134
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — 92.1% -43.0% -56.4% -76.1% -83.4% -90.9% -98.6% -97.7% -98.5% 1.3% 84.6% 2970.6% 9711.2% 223.7% 54.6% -5.5% 1.9% 4.1% 4.08%
Net Income — — -3.9% -1.6% -68.1% -71.3% -85.6% -1.2% -1.4% -56.8% -17.2% 15.9% 20.3% 1.1% 68.5% -7.1% -63.0% -22.4% -11.7% -3.5% -3.49%
EPS — — -82.3% 1.5% 37.2% 36.1% -84.7% -1.1% -1.4% -53.3% -14.5% 17.6% 21.5% 1.1% 69.0% -5.4% -60.1% -22.3% -11.5% -3.4% -3.44%
FCF — — -4.1% -1.0% 10.3% 40.9% 26.9% -1.2% -51.2% -47.6% -16.7% 20.5% 26.6% 1.2% 60.7% -20.7% -86.9% -14.2% -7.3% -2.7% -2.68%
EBITDA — — -3.9% -1.7% -70.9% -82.7% -1.1% -1.6% -1.9% -91.9% -32.3% 7.2% 16.5% 95.5% 56.9% 1.2% -37.4% -56.0% -6.2% -2.7% -2.70%
Op. Income — — -4.0% -1.7% -72.7% -82.6% -1.1% -1.6% -1.9% -90.1% -31.5% 7.6% 16.8% 95.4% 56.3% -4.6% -50.0% -57.2% -6.5% -2.6% -2.64%
OCF Growth snapshot only -2.72%
Asset Growth snapshot only -20.41%
Equity Growth snapshot only -93.49%
Debt Growth snapshot only 102.31%
Shares Change snapshot only 0.97%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — -83.2% -50.9% -18.5% 1.5% 1.9% 2.6% 3.1% 3.0% 4.3% 7.1% 7.11%
Revenue 5Y — — — — — — — — — — — — — — — — — — 1.2% 94.3% 94.28%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — -15.9% -15.4% -14.9% 78.8% 1.6% 89.5% 1.1% 5.2% 2.0% -1.2% -1.21%
Assets 5Y — — — — — — — — — — — — — — — — — — -5.5% -7.4% -7.43%
Equity 3Y — — — — — — — — — — -15.3% -14.9% -15.4% — -7.9% — 78.7% -25.2% -38.3% -63.1% -63.08%
Book Value 3Y — — — — — — — — — — -39.7% -39.5% -39.8% — -9.3% — 75.6% -26.4% -39.4% -63.6% -63.63%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — — 0.18 1.00 0.99 0.91 0.49 0.86 0.33 0.55 0.57 0.59 0.60 0.77 0.64 0.64 0.637
Earnings Stability — — — — — — 1.00 0.97 0.91 0.99 0.97 0.77 0.70 0.10 0.17 0.70 0.85 0.35 0.50 0.60 0.605
Margin Stability — — — — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — 0.50 0.50 0.50 0.50 0.93 0.94 0.92 0.20 0.50 0.97 0.50 0.20 0.50 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — -0.12 — 0.25 — -0.10 — 0.38 0.21 0.12 -0.04 -0.29 -1.40 -3.08 -16.99 -16.989
Gross Margin Trend — — — — — — -17.88 -74.46 -549.46 -661.87 -1871.48 20.47 278.51 339.48 953.16 51.37 279.26 334.24 942.21 11.44 11.437
FCF Margin Trend — — — — — — -57.64 -239.52 -2076.77 -1959.88 -5319.31 50.02 1037.93 1006.13 2714.52 170.82 1054.19 988.58 2678.94 42.79 42.786
Sustainable Growth Rate — — — — — — — — — — — — — 3.3% — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — 2.8% — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 3.01 3.30 2.69 2.21 1.61 1.16 1.08 1.04 1.01 1.09 1.08 0.98 0.93 1.69 1.31 1.10 1.07 1.00 0.88 0.91 0.912
FCF/OCF 1.02 1.02 1.02 1.01 1.02 1.00 1.01 1.01 1.01 1.00 1.00 1.00 1.00 0.96 1.03 1.01 1.01 1.00 1.00 1.00 1.001
FCF/Net Income snapshot only 0.913
CapEx/Revenue 17.3% 24.9% 33.5% 28.2% 30.1% 15.1% 55.1% 1.7% 13.1% 5.8% 6.5% 14.6% 6.6% 0.6% 0.6% 0.5% 0.4% 0.4% 0.3% 0.2% 0.17%
CapEx/Depreciation snapshot only 0.055
Accruals Ratio 0.09 0.76 0.11 0.14 0.08 0.03 0.01 0.01 0.01 0.02 0.02 -0.00 -0.01 -0.02 0.02 0.02 0.02 -0.00 -0.07 -0.07 -0.068
Sloan Accruals snapshot only -0.315
Cash Flow Adequacy snapshot only -996.980
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — 0.0% — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — 0.0% — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — 0.0% — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.3% -0.6% -0.4% -0.2% -0.1% -0.0% -0.0% -0.4% -1.0% -1.1% -0.6% -0.4% -0.2% -0.3% -0.3% -0.3% -0.5% -0.5% -0.6% -0.4% -0.39%
Total Shareholder Return -0.3% -0.6% -0.4% -0.2% -0.1% -0.0% -0.0% -0.4% -1.0% -1.1% -0.6% -0.4% -0.2% -0.3% -0.3% -0.3% -0.5% -0.5% -0.6% -0.4% -0.39%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.97 1.02 1.01 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.04 1.04 1.03 1.02 1.01 0.98 0.90 0.87 0.85 0.81 0.80 0.79 0.81 -2.69 0.57 0.84 0.93 0.98 1.01 1.02 1.023
EBIT Margin -3.05 -3.53 -5.45 -9.97 -12.09 -26.99 -70.03 -280.32 -2424.57 -2250.67 -6199.90 -113.47 -23.56 -0.03 -0.28 -0.50 -0.60 -2.07 -1.98 -1.80 -1.801
Asset Turnover 0.01 0.09 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.31 0.35 0.42 0.48 0.25 0.32 0.42 0.415
Equity Multiplier 1.06 -1.97 1.05 1.35 1.10 1.42 1.05 1.49 1.10 1.02 1.03 1.04 1.06 1.20 1.23 1.31 1.69 1.83 2.12 2.75 2.748
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.43 $-0.58 $-0.24 $-0.26 $-0.27 $-0.37 $-0.45 $-0.56 $-0.64 $-0.57 $-0.52 $-0.46 $-0.51 $0.08 $-0.16 $-0.49 $-0.81 $-1.74 $-1.99 $-2.17 $-2.17
Book Value/Share $9.49 $-0.89 $3.13 $-0.47 $0.28 $2.90 $2.77 $2.62 $2.48 $2.40 $2.32 $2.22 $2.07 $2.62 $2.34 $1.96 $1.49 $1.16 $0.62 $0.13 $0.13
Tangible Book/Share $9.49 $-0.89 $3.13 $-0.47 $0.28 $2.90 $2.77 $2.62 $2.48 $2.40 $2.31 $2.22 $1.99 $2.54 $2.26 $1.82 $1.35 $1.01 $0.47 $-0.01 $-0.01
Revenue/Share $0.14 $0.16 $0.04 $0.03 $0.02 $0.01 $0.01 $0.00 $0.00 $0.00 $0.00 $0.01 $0.03 $0.91 $0.99 $1.14 $1.44 $0.86 $1.00 $1.18 $1.18
FCF/Share $-1.32 $-1.94 $-0.67 $-0.59 $-0.44 $-0.43 $-0.49 $-0.59 $-0.66 $-0.62 $-0.56 $-0.46 $-0.47 $0.13 $-0.21 $-0.54 $-0.87 $-1.74 $-1.77 $-1.98 $-1.98
OCF/Share $-1.30 $-1.91 $-0.66 $-0.58 $-0.44 $-0.43 $-0.48 $-0.58 $-0.65 $-0.62 $-0.55 $-0.46 $-0.47 $0.14 $-0.21 $-0.54 $-0.86 $-1.73 $-1.76 $-1.98 $-1.98
Cash/Share $8.59 $1.71 $2.71 $0.48 $0.40 $2.92 $2.81 $2.66 $2.53 $2.38 $2.32 $2.26 $2.11 $3.21 $2.81 $2.44 $2.92 $2.49 $2.02 $1.45 $1.45
EBITDA/Share $-0.41 $-0.55 $-0.23 $-0.25 $-0.26 $-0.37 $-0.50 $-0.64 $-0.76 $-0.70 $-0.64 $-0.59 $-0.62 $-0.03 $-0.27 $-0.57 $-0.84 $-1.74 $-1.94 $-2.08 $-2.08
Debt/Share $0.18 $0.26 $0.06 $0.08 $0.07 $0.01 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.02 $0.02 $0.98 $0.97 $1.73 $1.73
Net Debt/Share $-8.41 $-1.46 $-2.65 $-0.40 $-0.33 $-2.91 $-2.80 $-2.65 $-2.53 $-2.37 $-2.32 $-2.26 $-2.11 $-3.21 $-2.81 $-2.42 $-2.90 $-1.50 $-1.05 $0.28 $0.28
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -1.921
Altman Z-Prime snapshot only -3.643
Piotroski F-Score 1 1 1 1 0 3 2 3 3 2 2 6 4 6 3 2 1 1 3 2 2
Beneish M-Score — — 57.84 -4.95 -5.74 — -34.00 -39.57 — — — -339.58 — — — 44.16 12.45 4.56 -0.99 -1.72 -1.723
Ohlson O-Score snapshot only -0.124
Net-Net WC snapshot only $-0.26
EVA snapshot only $-174877930.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only B-
Credit Score 72.98 20.00 74.73 20.00 74.80 65.57 64.83 65.15 65.42 76.56 76.19 76.32 76.07 83.18 76.01 76.16 59.28 51.27 26.68 22.45 22.454
Credit Grade snapshot only 16
Credit Trend snapshot only -53.709
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 11
Sector Credit Rank snapshot only 12

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms